Next Article in Journal
Wound Healing Effect of Essential Oil Extracted from Eugenia dysenterica DC (Myrtaceae) Leaves
Next Article in Special Issue
Antitrypanosomal Activity of Sesquiterpene Lactones from Helianthus tuberosus L. Including a New Furanoheliangolide with an Unusual Structure
Previous Article in Journal
Advances in the Synthesis of Lignan Natural Products
Previous Article in Special Issue
Solvent Extraction and Identification of Active Anticariogenic Metabolites in Piper cubeba L. through 1H-NMR-Based Metabolomics Approach
Article Menu
Issue 1 (January-1) cover image

Export Article

Open AccessArticle
Molecules 2019, 24(1), 1;

Antileishmanial Activity of Dimeric Flavonoids Isolated from Arrabidaea brachypoda

Laboratório de Engenharia Tecidual e Imunofarmacologia, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (Fiocruz), Avenida Waldemar Falcão, 121, Candeal–Salvador-BA 40296-710, Brazil
Departamento de Química, Universidade Federal do Maranhão, São Luiz 65080-805, MA, Brazil
School of Pharmaceutical Sciences, EPGL, University of Geneva, University of Lausanne, CMU, 1, Rue Michel Servet, 1211 Geneva, Switzerland
UNESP-Campus Experimental do Litoral Paulista, Praça Infante Dom Henrique s/n°, Parque Bitaru, São Vicente–SP 11330-900, Brazil
Author to whom correspondence should be addressed.
Academic Editor: Thomas J. Schmidt
Received: 20 November 2018 / Revised: 10 December 2018 / Accepted: 19 December 2018 / Published: 20 December 2018
Full-Text   |   PDF [3290 KB, uploaded 20 December 2018]   |  


Leishmaniasis are diseases caused by parasites belonging to Leishmania genus. The treatment with pentavalent antimonials present high toxicity. Secondary line drugs, such as amphotericin B and miltefosine also have a narrow therapeutic index. Therefore, there is an urgent need to develop new drugs to treat leishmaniasis. Here, we present the in vitro anti-leishmanial activity of unusual dimeric flavonoids purified from Arrabidaea brachypoda. Three compounds were tested against Leishmana sp. Compound 2 was the most active against promastigotes. Quantifying the in vitro infected macrophages revealed that compound 2 was also the most active against intracellular amastigotes of L. amazonensis, without displaying host cell toxicity. Drug combinations presented an additive effect, suggesting the absence of interaction between amphotericin B and compound 2. Amastigotes treated with compound 2 demonstrated alterations in the Golgi and accumulation of vesicles inside the flagellar pocket. Compound 2-treated amastigotes presented a high accumulation of cytoplasmic vesicles and a myelin-like structure. When administered in L. amazonensis-infected mice, neither the oral nor the topical treatments were effective against the parasite. Based on the high in vitro activity, dimeric flavonoids can be used as a lead structure for the development of new molecules that could be useful for structure-active studies against Leishmania. View Full-Text
Keywords: Leishmania; flavonoids; high content; Arrabidaea brachypoda Leishmania; flavonoids; high content; Arrabidaea brachypoda

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Rocha, V.P.C.; Quintino da Rocha, C.; Ferreira Queiroz, E.; Marcourt, L.; Vilegas, W.; Grimaldi, G.B.; Furrer, P.; Allémann, É.; Wolfender, J.-L.; Soares, M.B.P. Antileishmanial Activity of Dimeric Flavonoids Isolated from Arrabidaea brachypoda. Molecules 2019, 24, 1.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top